心室辅助装置植入相关急性肾损伤:全国趋势与结局估计
该研究基于美国20%分层住院样本,分析2006至2015年植入式心室辅助装置(VAD)住院患者中急性肾损伤(AKI)及需透析AKI(AKI-D)的诊断趋势与结局。结果显示AKI诊断率从44.0%升至61.7%,AKI-D从9.3%降至5.2%,但AKI-D患者死亡率下降幅度最小,且住院费用显著更高。
要点
- VAD植入患者AKI诊断率从44.0%增至61.7%,AKI-D从9.3%降至5.2%。
- AKI-D患者死亡率下降幅度最小,仍处高位。
- AKI和AKI-D患者调整后住院费用分别高19.1%和39.6%。
核心结论
- VAD植入患者中AKI-D比例下降,但AKI-D患者死亡率仍高;AKI诊断率上升可能反映监测与编码变化。
研究设计与样本
- 基于美国20%分层住院样本的队列研究,纳入2006至2015年植入式VAD植入患者。
主要发现
- 估计共植入24,140例VAD,从2006年853例增至2015年3,945例。
- AKI诊断率为56.1%,AKI-D发生率为6.5%。
- AKI诊断率从2006-2007年44.0%升至2014-2015年61.7%,AKI-D从9.3%降至5.2%。
- 各AKI类别死亡率均下降,但AKI-D患者下降幅度最小。
- 调整后住院费用:AKI患者比无AKI高19.1%,AKI-D患者高39.6%。
临床怎么用
- VAD植入患者应重视AKI监测,尤其需透析者死亡风险高、费用负担大。
局限性
- 使用行政数据,无法确定AKI与VAD植入的时间关系。
- 既往慢性肾脏病 ascertainment 有限。
- 出院权重未针对目标亚组推导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Ventricular assist devices (VADs) are used for end-stage heart failure not amenable to medical therapy. Acute kidney injury (AKI) in this setting is common due to heart failure decompensation, surgical stress, and other factors. Little is known about national trends in AKI diagnosis and AKI requiring dialysis (AKI-D) and associated outcomes with VAD implantation. We investigated national estimates and trends for diagnosed AKI, AKI-D, and associated patient and resource utilization outcomes in hospitalizations in which implantable VADs were placed. STUDY DESIGN: Cohort study of 20% stratified sample of US hospitalizations. SETTING & PARTICIPANTS: Patients who underwent implantable VAD placement in 2006 to 2015. EXPOSURE: No AKI diagnosis, AKI without dialysis, AKI-D. OUTCOMES: In-hospital mortality, length of stay, estimated hospitalization costs. ANALYTICAL APPROACH: Multivariate logistic and linear regression using survey design methods to account for stratification, clustering, and weighting. RESULTS: An estimated 24,140 implantable VADs were placed, increasing from 853 in 2006 to 3,945 in 2015. AKI was diagnosed in 56.1% of hospitalizations and AKI-D occurred in 6.5%. AKI diagnosis increased from 44.0% in 2006 to 2007 to 61.7% in 2014 to 2015; AKI-D declined from 9.3% in 2006 to 2007 to 5.2% in 2014 to 2015. Mortality declined in all AKI categories but this varied by category: those with AKI-D had the smallest decline. Adjusted hospitalization costs were 19.1% higher in those with diagnosed AKI and 39.6% higher in those with AKI-D, compared to no AKI. LIMITATIONS: Administrative data; timing of AKI with respect to VAD implantation cannot be determined; limited pre-existing chronic kidney disease ascertainment; discharge weights not derived for subpopulation of interest. CONCLUSIONS: A decreasing proportion of patients undergoing VAD implantation experience AKI-D, but mortality among these patients remains high. AKI diagnosis with VAD implantation is increasing, possibly reflecting changes in AKI surveillance, awareness, and coding.
引用
- Walther CP, Winkelmayer WC, Niu J, et al. Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis. 2019. PMID: 31160142. doi:10.1053/j.ajkd.2019.03.423
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。